Mean body weight and weight gain were decreased up to 18% in females in all drug groups relative to control values. A NOAEL could not be determined and, at the lowest tested dose of 3 mg/kg/day, there is no safety margin relative to the systemic exposures (AUC0-24) for aripiprazole ...
The recommended target dose of ABILIFY is 10 mg/day. Aripiprazole was studied in adolescent patients 13 to 17 years of age with schizophrenia at daily doses of 10 and 30 mg. The starting daily dose of the tablet formulation in these patients was 2 mg, which was titrated to 5 mg after ...
We aimed to evaluate the dose effects of adjunctive treatment with aripiprazole on prolactin levels and hyperprolactinemia in schizophrenia patients. Stable subjects 18鈥 45 years old with schizophrenia and hyperprolactinemia (i.e., >24ng/ml for females and >20ng/ml for males) were randomly ...
(BUN) > 2 × upper limit of normal (ULN); (4) patients with a prolonged QTc interval (QTc ≥ 450 ms in males and QTc ≥ 470 ms in females); (5) patients who received modified electroconvulsive therapy (MECT) within two month prior to enrollment; (6) ...
Abilify Maintena has not been studied in pregnant women. Abilify Maintena is excreted in breast milk. Nursing mothers should consult their doctors before breastfeeding. Additional Information Our Abilify Maintena (aripiprazole) Side Effects Drug Center provides a comprehensive view of available drug inform...
Secondary outcomes were metabolic, endocrine, extrapyramidal and cardiac side effects and drug effectiveness.METHODS\nTwenty-four children and adolescents (15 males, 9 females) aged 6-18 years were included in a 24-week prospective observational trial. Drug plasma concentrations, side effects an...
Side Effects for Aripiprazole Tablets Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice...